HomeInsightsPE

Bal Pharma Ltd PE Ratio

Bal Pharma Ltd PE Ratio

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

6.4 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 24, 2024

Image

Bal Pharma Ltd

NSE: BALPHARMA

PE

28.3

Last updated on: Nov 24, 2024

Key Highlights

  • The P/E Ratio of Bal Pharma Ltd is 28.3 as of 24 Nov 9.00 AM .
  • The P/E Ratio of Bal Pharma Ltd changed from 26.4 on March 2019 to 19.5 on March 2024 . This represents a CAGR of -4.92% over 6 years.
  • The Latest Trading Price of Bal Pharma Ltd is ₹ 135.9 as of 22 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Bal Pharma Ltd

No data available

Company Fundamentals for Bal Pharma Ltd

No data available

Image

Bal Pharma Ltd

NSE: BALPHARMA

Share Price

₹ 135.9

-0.95 (-0.69%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Bal Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Bal Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024135.9
21 Nov 2024136.85
19 Nov 2024131.05
18 Nov 2024125.65
14 Nov 2024119.7
13 Nov 2024114
12 Nov 2024118.9
11 Nov 2024120.65
08 Nov 2024125.8
07 Nov 2024126.1

SWOT Analysis Of Bal Pharma Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Bal Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Bal Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Bal Pharma Ltd28216
Sun Pharmaceuticals Industries Ltd384,31,352
Divis Laboratories Ltd861,59,265
Cipla Ltd261,20,033
Torrent Pharmaceuticals Ltd611,07,301
Mankind Pharma Ltd481,02,231

Key Valuation Metric of Bal Pharma Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Bal Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Bal Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Bal Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Bal Pharma Ltd

No data available

* All values are in crore

Historical Dividend Payout of Bal Pharma Ltd

No data available

* All values are in %

About Bal Pharma Ltd

  • Bal Pharma Ltd (BPL), a member of the Mcro Laboratories Group, was incorporated as a private limited company in May '87.
  • In Mar.'90, BPL took over a pharmaceutical products manufacturing unit located in Bangalore through the Karnataka State Finance Corporation for a consideration of Rs 25.18 lac following which, BPL commenced manufacturing formulations. BPL manufactures and markets pharmaceutical formulations -- paracetamol, aluminium hydroxide, povidone iodine, alprazolam, gliclazide, griseofulvin, lactobacillus, rifampicin, piroxicam amoxycillin, etc.
  • The company promotes its products through the common sales force of the group but proposes to induct its own soon.
  • It came out with a public issue in Feb.'95 for manufacture of bulk drugs and expansion of pharmaceutical formulations. During 1997-98, the formalities of takeover of the unit from Lakme Limited have been completed and effective from 23rd July, 1997 the unit has become a division of Bal Pharma Limited.

Bal Pharma Ltd News Hub

News

Bal Pharma schedules AGM

Bal Pharma announced that the Annual General Meeting (AGM) of the company will be held on ...

Read more

2024-08-16 00:00:00

News

Bal Pharma consolidated net profit rises 225.00% in the June 2024 quarter

Net profit of Bal Pharma rose 225.00% to Rs 0.26 crore in the quarter ended June 2024 as a...

Read more

2024-08-13 00:00:00

News

Bal Pharma to convene board meeting

Bal Pharma will hold a meeting of the Board of Directors of the Company on 9 September 202...

Read more

2024-08-31 00:00:00

News

Bal Pharma schedules board meeting

Bal Pharma will hold a meeting of the Board of Directors of the Company on 14 November 202...

Read more

2024-11-06 00:00:00

News

Bal Pharma consolidated net profit rises 9.47% in the September 2024 quarter

Net profit of Bal Pharma rose 9.47% to Rs 1.04 crore in the quarter ended September 2024 a...

Read more

2024-11-15 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Bal Pharma Ltd

What is the current PE Ratio of Bal Pharma Ltd?

The Current PE Ratio of Bal Pharma Ltd is 28.25 as on 24 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 24 Nov 2024.

What was the PE Ratio of Bal Pharma Ltd last year?

The PE Ratio of Bal Pharma Ltd was 40.81 last year, now the PE ratio is 28.25, showing a year-on-year growth of -30.8%.

What does the PE Ratio of Bal Pharma Ltd indicate about its stock?

The PE Ratio of Bal Pharma Ltd is 28.25. This ratio indicates that investors are willing to pay 28.25 times the earnings per share for each share of Bal Pharma Ltd.

What is the PE Ratio Growth of Bal Pharma Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Bal Pharma Ltd grew by -30.8% whereas, the EPS ratio grew by 306.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*